Louisiana State Employees Retirement System Has $2.12 Million Stock Holdings in Kenvue Inc. $KVUE

Louisiana State Employees Retirement System cut its stake in shares of Kenvue Inc. (NYSE:KVUE) by 1.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 101,300 shares of the company’s stock after selling 1,800 shares during the period. Louisiana State Employees Retirement System’s holdings in Kenvue were worth $2,120,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Evergreen Wealth Solutions LLC raised its position in shares of Kenvue by 2.6% during the first quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock worth $402,000 after purchasing an additional 432 shares during the period. Scott & Selber Inc. raised its position in shares of Kenvue by 0.4% during the first quarter. Scott & Selber Inc. now owns 106,621 shares of the company’s stock worth $2,557,000 after purchasing an additional 475 shares during the period. Wealth Alliance LLC raised its position in shares of Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock worth $762,000 after purchasing an additional 486 shares during the period. Everett Harris & Co. CA raised its position in shares of Kenvue by 1.4% during the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company’s stock worth $887,000 after purchasing an additional 500 shares during the period. Finally, UMB Bank n.a. raised its position in Kenvue by 22.3% during the second quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock valued at $60,000 after buying an additional 521 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

KVUE has been the topic of several recent analyst reports. JPMorgan Chase & Co. dropped their price target on Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday. Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Canaccord Genuity Group dropped their price target on Kenvue from $29.00 to $26.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Evercore ISI dropped their price target on Kenvue from $23.00 to $18.00 and set an “in-line” rating on the stock in a research report on Tuesday, September 23rd. Finally, UBS Group dropped their price target on Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $21.18.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $16.68 on Friday. The business’s 50-day moving average price is $19.15 and its two-hundred day moving average price is $21.34. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. Kenvue Inc. has a one year low of $15.47 and a one year high of $25.17. The company has a market capitalization of $32.00 billion, a P/E ratio of 22.53, a price-to-earnings-growth ratio of 2.42 and a beta of 0.72.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the company posted $0.32 earnings per share. The business’s quarterly revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. This represents a $0.83 annualized dividend and a dividend yield of 5.0%. Kenvue’s dividend payout ratio is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.